Holen Sie sich die Stockscreener-App
0.9345
12.63%
0.1005
Invivyd Inc Aktie (IVVD) Neueste Nachrichten
symbol__ Stock Quote Price and Forecast - CNN
Healthcare Stocks Decline as Investors Rotate Away From Safety -- Healthcare Roundup - Moomoo
Invivyd receives FDA termination notice for PEMGARDA EUA - grafa.com
IVVD Stock Tanks 19% Today – But This Analyst Believes It Has A Potential Upside Of Over 730% - Stocktwits
Invivyd gets notice of Pemgarda EUA termination - MSN
Invivyd (NASDAQ: IVVD) faces 2027 end of PEMGARDA COVID EUA - Stock Titan
Invivyd, Inc. Announces FDA Notice of Termination for PEMGARDA EUA Following HHS COVID-19 Emergency Declaration Wind-Down - Quiver Quantitative
PEMGARDA faces 2027 EUA end as Invivyd talks next steps with FDA - Stock Titan
IVVDInvivyd Inc Short Interest - Finviz
Price to sales forward of Invivyd, Inc. – NASDAQ:IVVD - TradingView
Invivyd gives 14 new hires stock options worth 493,000 shares - Stock Titan
IVVD News | INVIVYD INC (NASDAQ:IVVD) - ChartMill
New Haven biotech company developing measles treatment as US cases top 2,100 - WFSB
Invivyd, Inc.(NasdaqGM: IVVD) added to Russell 2000 Index - marketscreener.com
Invivyd, Inc.(NasdaqGM: IVVD) added to Russell Microcap Value Benchmark Index - marketscreener.com
Invivyd, Inc.(NasdaqGM: IVVD) added to Russell 2000 Value Benchmark - marketscreener.com
Invivyd, Inc.(NasdaqGM: IVVD) added to Russell Microcap Index - marketscreener.com
Invivyd, Inc.(NasdaqGM: IVVD) added to Russell 3000 Index - marketscreener.com
Invivyd, Inc.(NasdaqGM: IVVD) added to Russell 3000E Value Benchmark - marketscreener.com
Invivyd, Inc. Actuals & Estimates (NASDAQ:IVVD) - TradingView
IVVD Forecast — Price Target — Prediction for 2027 - TradingView
Invivyd Shareholder Notice - TMX Newsfile
Lobbying Update: $60,000 of INVIVYD INC. lobbying was just disclosed - Quiver Quantitative
Invivyd, Inc. (IVVD) reports Q1 loss, lags revenue estimates - MSN
Invivyd Inc (IVVD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Invivyd Inc (IVVD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Invivyd Inc (IVVD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Invivyd, Inc.(NasdaqGM: IVVD) dropped from S&P Biotechnology Select Industry Index - marketscreener.com
Invivyd (IVVD) Doses First Participants in Phase 3 Trial for VYD2311 - Insider Monkey
INVIVYD INC (IVVD) Stock Chart - ChartMill
Invivyd, Inc. spotlights new data for solid organ transplant recipients in Boston - Traders Union
Invivyd Inc (IVVD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Invivyd Inc (IVVD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Invivyd Inc (IVVD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Invivyd Inc (IVVD) Institutional Confidence - TradingKey
Invivyd Inc (IVVD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Invivyd Inc (IVVD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Invivyd completes Phase 3 COVID-19 antibody trial enrollment - grafa.com
H.C. Wainwright reiterates Invivyd stock rating on trial progress By Investing.com - Investing.com South Africa
Invivyd's Late-Stage Trial of Covid Vaccine Alternative Completes Enrollment; Shares Rise Pre-Bell - Moomoo
Invivyd completes enrollment in Phase 3 COVID antibody trial By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Invivyd stock rating on trial progress - Investing.com
Invivyd completes enrollment in Phase 3 COVID antibody trial - Investing.com
Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine - The Manila Times
COVID antibody faces mRNA shots in Phase 3 side-effect study - Stock Titan
Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Rezolute (RZLT) and Invivyd (IVVD) - The Globe and Mail
IVVD Reiterated by HC Wainwright & Co. -- Price Target Maintained at $10 - GuruFocus
Invivyd doses first participants in phase 3 COVID-19 trial of VYD2311 - Contagion Live
Invivyd Inc (IVVD) Reports Clinical Progress. Stock Expected to Explode - Insider Monkey
Billionaire Lee Ainslie’s 10 Stocks with Huge Upside Potential - Insider Monkey
IVVD,VCEL Revenue Breakdown - Finviz
Invivyd doses first participants in Phase 3 COVID-19 trial - Proactive financial news
IVVD Reiterated by BTIG -- Price Target Maintained at $10 - GuruFocus
Invivyd doses first participants in Phase 3 LIBERTY trial - grafa.com
Small cap wrap: Royal Road Minerals, Miivo Holdings, Alvopetro, Arizona Gold & Silver... - Proactive financial news
1.16%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):